REPORT ID 2420

EMEA (Europe, Middle East and Africa) Non-opioid Analgesic Patch Market Report 2017

Publish Date
8-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Non-opioid Analgesic Patch market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Non-opioid Analgesic Patch for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Non-opioid Analgesic Patch market competition by top manufacturers/players, with Non-opioid Analgesic Patch sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline Plc
    Pfizer, Inc.
    Teikoku Seiyaku Co., Ltd.
    Mylan N.V.
    Hisamitsu Pharmaceutical Co.,Inc
    Acorda Therapeutics, Inc
    Endo International plc
    Allergan
    Teh Seng Pharmaceutical Mfg
    IBSA Institut Biochimque SA

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Lidocaine Patches
    Diclofenac Patches
    Methyl Salicylate Patches
    Capsaicin Patches
    Ketoprofen Patches
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Non-opioid Analgesic Patch Market Report 2017
1 Non-opioid Analgesic Patch Overview
    1.1 Product Overview and Scope of Non-opioid Analgesic Patch
    1.2 Classification of Non-opioid Analgesic Patch
        1.2.1 EMEA Non-opioid Analgesic Patch Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Non-opioid Analgesic Patch Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Lidocaine Patches
        1.2.4 Diclofenac Patches
        1.2.5 Methyl Salicylate Patches
        1.2.6 Capsaicin Patches
        1.2.7 Ketoprofen Patches
        1.2.8 Others
    1.3 EMEA Non-opioid Analgesic Patch Market by Application/End Users
        1.3.1 EMEA Non-opioid Analgesic Patch Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Independent Pharmacies & Drug Stores
    1.4 EMEA Non-opioid Analgesic Patch Market by Region
        1.4.1 EMEA Non-opioid Analgesic Patch Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Non-opioid Analgesic Patch (2012-2022)
        1.5.1 EMEA Non-opioid Analgesic Patch Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Non-opioid Analgesic Patch Revenue and Growth Rate (2012-2022)

2 EMEA Non-opioid Analgesic Patch Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Non-opioid Analgesic Patch Market Competition by Players/Manufacturers
        2.1.1 EMEA Non-opioid Analgesic Patch Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Non-opioid Analgesic Patch Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Non-opioid Analgesic Patch Sale Price by Players (2012-2017)
    2.2 EMEA Non-opioid Analgesic Patch (Volume and Value) by Type/Product Category
        2.2.1 EMEA Non-opioid Analgesic Patch Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Non-opioid Analgesic Patch Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Non-opioid Analgesic Patch Sale Price by Type (2012-2017)
    2.3 EMEA Non-opioid Analgesic Patch (Volume) by Application
    2.4 EMEA Non-opioid Analgesic Patch (Volume and Value) by Region
        2.4.1 EMEA Non-opioid Analgesic Patch Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Non-opioid Analgesic Patch Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Non-opioid Analgesic Patch Sales Price by Region (2012-2017)

3 Europe Non-opioid Analgesic Patch (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Non-opioid Analgesic Patch Sales and Value (2012-2017)
        3.1.1 Europe Non-opioid Analgesic Patch Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Non-opioid Analgesic Patch Revenue and Growth Rate (2012-2017)
    3.2 Europe Non-opioid Analgesic Patch Sales and Market Share by Type
    3.3 Europe Non-opioid Analgesic Patch Sales and Market Share by Application
    3.4 Europe Non-opioid Analgesic Patch Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Non-opioid Analgesic Patch Sales Volume by Countries (2012-2017)
        3.4.2 Europe Non-opioid Analgesic Patch Revenue by Countries (2012-2017)
        3.4.3 Germany Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        3.4.4 France Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        3.4.5 UK Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        3.4.6 Russia Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        3.4.7 Italy Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)

4 Middle East Non-opioid Analgesic Patch (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Non-opioid Analgesic Patch Sales and Value (2012-2017)
        4.1.1 Middle East Non-opioid Analgesic Patch Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Non-opioid Analgesic Patch Revenue and Growth Rate (2012-2017)
    4.2 Middle East Non-opioid Analgesic Patch Sales and Market Share by Type
    4.3 Middle East Non-opioid Analgesic Patch Sales and Market Share by Application
    4.4 Middle East Non-opioid Analgesic Patch Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Non-opioid Analgesic Patch Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Non-opioid Analgesic Patch Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        4.4.4 Israel Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        4.4.5 UAE Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        4.4.6 Iran Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)

5 Africa Non-opioid Analgesic Patch (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Non-opioid Analgesic Patch Sales and Value (2012-2017)
        5.1.1 Africa Non-opioid Analgesic Patch Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Non-opioid Analgesic Patch Revenue and Growth Rate (2012-2017)
    5.2 Africa Non-opioid Analgesic Patch Sales and Market Share by Type
    5.3 Africa Non-opioid Analgesic Patch Sales and Market Share by Application
    5.4 Africa Non-opioid Analgesic Patch Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Non-opioid Analgesic Patch Sales Volume by Countries (2012-2017)
        5.4.2 Africa Non-opioid Analgesic Patch Revenue by Countries (2012-2017)
        5.4.3 South Africa Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Non-opioid Analgesic Patch Sales and Growth Rate (2012-2017)

6 EMEA Non-opioid Analgesic Patch Manufacturers/Players Profiles and Sales Data
    6.1 GlaxoSmithKline Plc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer, Inc.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Teikoku Seiyaku Co., Ltd.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Mylan N.V.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Mylan N.V. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Hisamitsu Pharmaceutical Co.,Inc
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Acorda Therapeutics, Inc
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Endo International plc
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Endo International plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Allergan
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Allergan Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Teh Seng Pharmaceutical Mfg
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 IBSA Institut Biochimque SA
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Non-opioid Analgesic Patch Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Non-opioid Analgesic Patch Manufacturing Cost Analysis
    7.1 Non-opioid Analgesic Patch Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Non-opioid Analgesic Patch Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Non-opioid Analgesic Patch Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Non-opioid Analgesic Patch Market Forecast (2017-2022)
    11.1 EMEA Non-opioid Analgesic Patch Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Non-opioid Analgesic Patch Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Non-opioid Analgesic Patch Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Non-opioid Analgesic Patch Price and Trend Forecast (2017-2022)
    11.2 EMEA Non-opioid Analgesic Patch Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Non-opioid Analgesic Patch Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Non-opioid Analgesic Patch Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Non-opioid Analgesic Patch Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Non-opioid Analgesic Patch Sales Forecast by Type (2017-2022)
    11.7 EMEA Non-opioid Analgesic Patch Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer